ClinConnect ClinConnect Logo
Search / Trial NCT04906408

The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR

Launched by OHIO STATE UNIVERSITY · May 24, 2021

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Infection Seroma Hematoma Skin Necrosis Ec Fistula Mesh Infection Hernia Recurrence Bulge Prevena Prineo Abdominal Wall Reconstruction Sso Dressings

ClinConnect Summary

This clinical trial is studying how different types of dressings used after surgery can affect healing in patients who are having surgery for abdominal hernias. Specifically, it will compare three types of dressings: Prevena, Prineo, and traditional dressings. The goal is to see which dressing helps reduce the risk of complications at the surgical site.

To participate in this trial, you need to be over 18 years old and scheduled for elective surgery to repair a ventral hernia, which is a common type of abdominal hernia. You should be in good health overall, meaning you don’t have serious heart, lung, or kidney diseases. Importantly, you must be able to have your incision closed after surgery. If you join the trial, you will receive one of the three types of dressings after your surgery and will be monitored to see how well you heal. If you have any allergies to the materials used in these dressings or are a smoker, you may not be eligible to participate. This study is important as it could help improve recovery for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18
  • Patients presenting for elective ventral hernia repair
  • Patients deemed to be good surgical candidates, with no active life-threatening cardiac disease, pulmonary disease, renal disease, hematologic disease -Patients who will have a closed incision following the surgery
  • Exclusion Criteria:
  • Known allergy to any material used in any wound treatment (Prevena- Acrylic adhesive or silver, Prineo- Dermabond glue, Standard- Bacitracin, Xeroform, surgical tape) -Active smokers (within the past 4 weeks) presenting for elective hernia repair
  • Patients with active life-threatening cardiac disease, pulmonary disease, renal disease, hematologic disease presenting for elective ventral hernia repair
  • Patients presenting for emergent ventral hernia repair (in the setting of bowel strangulation, necrosis, penetrating trauma) as it will be difficult to consent those patients for the study preoperatively
  • Patients with severe systemic sepsis
  • Patients with frank purulence in the wound -Patients with an open wound following surgery -Patients undergoing a panniculectomy

About Ohio State University

The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.

Locations

Columbus, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Jeffrey E Janis, MD

Principal Investigator

Ohio State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials